Volume 164, Issue 1, Pages (January 2016)

Slides:



Advertisements
Similar presentations
by Prarthana Mohanraju, Kira S
Advertisements

A CRISPR View of Cleavage
Volume 161, Issue 5, Pages (May 2015)
Expanding the Biologist’s Toolkit with CRISPR-Cas9
CRISPR/Cas9 GENOMICS Lucía Álvarez González
CRISPR-Cas Systems: Prokaryotes Upgrade to Adaptive Immunity
Volume 56, Issue 4, Pages (November 2014)
Virginia J. Bruce, Brian R. McNaughton  Cell Chemical Biology 
Volume 62, Issue 2, Pages (April 2016)
Rewiring Cas9 to Target New PAM Sequences
Development and Applications of CRISPR-Cas9 for Genome Engineering
Archaeal CRISPR-based immune systems: exchangeable functional modules
Volume 60, Issue 3, Pages (November 2015)
The Interfaces of Genetic Conflict Are Hot Spots for Innovation
DNase H Activity of Neisseria meningitidis Cas9
Calorie Restriction à Lamarck
CRISPR CRISPRs (clustered regularly interspaced short palindromic repeats) are repetitive nucleotide sequences followed by a short spacer DNA segments.
Harnessing CRISPR–Cas systems for bacterial genome editing
CRISPR-Cas Systems: Prokaryotes Upgrade to Adaptive Immunity
Addison V. Wright, James K. Nuñez, Jennifer A. Doudna  Cell 
The CRISPR/Cas9 system.1 Clustered regularly interspaced palindromic repeats (CRISPR) refers to sequences in the bacterial genome. The CRISPR/Cas9 system.1.
Volume 45, Issue 3, Pages (February 2012)
Mouse Genome Engineering via CRISPR-Cas9 for Study of Immune Function
Volume 65, Issue 1, Pages (January 2017)
Figure 1 Adaptive immune system of bacteria and archaea
Volume 50, Issue 4, Pages (May 2013)
Single-Stranded DNA Cleavage by Divergent CRISPR-Cas9 Enzymes
CRISPR-Cas9 for in vivo Gene Therapy: Promise and Hurdles
Therapeutic editing of hepatocyte genome in vivo
USH2A Gene Editing Using the CRISPR System
The CRISPR/Cas9 system.1 Clustered regularly interspaced palindromic repeats (CRISPR) refers to sequences in the bacterial genome. The CRISPR/Cas9 system.1.
Joseph Bondy-Denomy, Alan R. Davidson  Trends in Microbiology 
Guide RNA Functional Modules Direct Cas9 Activity and Orthogonality
Volume 22, Issue 3, Pages e3 (September 2017)
RNA-Guided Genome Editing in Plants Using a CRISPR–Cas System
Dipali G. Sashital, Blake Wiedenheft, Jennifer A. Doudna 
RNAi: Prokaryotes Get in on the Act
Zinc Fingers, TAL Effectors, or Cas9-Based DNA Binding Proteins: What’s Best for Targeting Desired Genome Loci?  Annett Strauβ, Thomas Lahaye  Molecular.
Programmable RNA Cleavage and Recognition by a Natural CRISPR-Cas9 System from Neisseria meningitidis  Beth A. Rousseau, Zhonggang Hou, Max J. Gramelspacher,
Ryan N. Jackson, Blake Wiedenheft  Molecular Cell 
Volume 69, Issue 5, Pages e7 (March 2018)
The Evolution of Antiviral Defense Systems
Bacterial scissors to edit human embryos?
Picking Pyknons out of the Human Genome
Advances in Industrial Biotechnology Using CRISPR-Cas Systems
Volume 69, Issue 1, Pages e3 (January 2018)
Proteins Kinases: Chromatin-Associated Enzymes?
Zhao Zhang, Yuelin Zhang, Fei Gao, Shuo Han, Kathryn S
A CRISPR Approach to Gene Targeting
William T. Hendriks, Curtis R. Warren, Chad A. Cowan  Cell Stem Cell 
Regulatory RNAs in Bacteria
Nadja Heidrich, Jörg Vogel  Molecular Cell 
Structure of an RNA Silencing Complex of the CRISPR-Cas Immune System
Divergent Transcription: A Driving Force for New Gene Origination?
Hayun Lee, Yi Zhou, David W. Taylor, Dipali G. Sashital  Molecular Cell 
The Cell Biology of Genomes: Bringing the Double Helix to Life
DNA Unwinding Is the Primary Determinant of CRISPR-Cas9 Activity
Gene editing: modifying a gene that was already there
Development and Applications of CRISPR-Cas9 for Genome Engineering
Ciaran M Lee, Thomas J Cradick, Gang Bao  Molecular Therapy 
CRISPR/Cas Systems towards Next-Generation Biosensing
Volume 41, Issue 2, Pages (January 2011)
The Biology of CRISPR-Cas: Backward and Forward
Adaptation in CRISPR-Cas Systems
Chemical Biology Approaches to Genome Editing: Understanding, Controlling, and Delivering Programmable Nucleases  Johnny H. Hu, Kevin M. Davis, David R.
Volume 16, Issue 11, Pages (September 2016)
Thomas Gaj, Benjamin E Epstein, David V Schaffer  Molecular Therapy 
CRISPR Immunological Memory Requires a Host Factor for Specificity
Volume 26, Issue 3, Pages e5 (September 2019)
Potent and sequence-specific removal through genome targeting with CRISPR-Cas systems. Potent and sequence-specific removal through genome targeting with.
Presentation transcript:

Volume 164, Issue 1, Pages 18-28 (January 2016) The Heroes of CRISPR  Eric S. Lander  Cell  Volume 164, Issue 1, Pages 18-28 (January 2016) DOI: 10.1016/j.cell.2015.12.041 Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 1 Class 2, Type II CRISPR-Cas9 System from Streptococcus thermophilus Type II systems are the simplest of the three types of CRISPR systems and have been the basis for genome editing technology. (A) The locus contains a CRISPR array, four protein-coding genes (cas9, cas1, cas2, and cns2) and the tracrRNA. The CRISPR array contains repeat regions (black diamonds) separated by spacer regions (colored rectangles) derived from phage and other invading genetic elements. The cas9 gene encodes a nuclease that confers immunity by cutting invading DNA that matches existing spacers, while the cas1, cas2, and cns2 genes encode proteins that function in the acquisition of new spacers from invading DNA. (B) The CRISPR array and the tracrRNA are transcribed, giving rise to a long pre-crRNA and a tracrRNA. (C) These two RNAs hybridize via complementary sequences and are processed to shorter forms by Cas9 and RNase III. (D) The resulting complex (Cas9 + tracrRNA + crRNA) then begins searching for the DNA sequences that match the spacer sequence (shown in red). Binding to the target site also requires the presence of the protospacer adjacent motif (PAM), which functions as a molecular handle for Cas9 to grab on to. (E) Once Cas9 binds to a target site with a match between the crRNA and the target DNA, it cleaves the DNA three bases upstream of the PAM site. Cas9 contains two endonuclease domains, HNH and RuvC, which cleave, respectively, the complementary and non-complementary strands of the target DNA, creating blunt ends. Cell 2016 164, 18-28DOI: (10.1016/j.cell.2015.12.041) Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 2 The Twenty-Year Story of CRISPR Unfolded across Twelve Cities in Nine Countries For each “chapter” in the CRISPR “story,” the map shows the sites where the primary work occurred and the first submission dates of the papers. Green circles refer to the early discovery of the CRISPR system and its function; red to the genetic, molecular biological, and biochemical characterization; and blue to the final step of biological engineering to enable genome editing. Cell 2016 164, 18-28DOI: (10.1016/j.cell.2015.12.041) Copyright © 2016 Elsevier Inc. Terms and Conditions